KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Prepaid Assets (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 17 years of Prepaid Assets data on record, last reported at $110.9 million in Q4 2025.

  • For Q4 2025, Prepaid Assets fell 83.34% year-over-year to $110.9 million; the TTM value through Dec 2025 reached $110.9 million, down 83.34%, while the annual FY2025 figure was $110.9 million, 83.34% down from the prior year.
  • Prepaid Assets reached $110.9 million in Q4 2025 per VRTX's latest filing, down from $709.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $726.9 million in Q3 2022 and bottomed at $74.4 million in Q4 2022.
  • Average Prepaid Assets over 5 years is $505.5 million, with a median of $525.6 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: plummeted 86.37% in 2022, then soared 738.31% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $545.8 million in 2021, then tumbled by 86.37% to $74.4 million in 2022, then skyrocketed by 738.31% to $623.7 million in 2023, then rose by 6.73% to $665.7 million in 2024, then crashed by 83.34% to $110.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $110.9 million in Q4 2025, $709.4 million in Q3 2025, and $652.3 million in Q2 2025.